Myers Michael — SEC Form 4 filings
SEC reporting owner CIK 1959547. 7 Form 4 filings on record with FilingPulse; latest filed 2026-09-01.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2024-09-05 to 2026-09-01. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 6 legs across 3 filings — 613,940 shares, $378,908 total (shares × price as filed).
- Open-market sales (code S, non-derivative): none reported.
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: purchase of 555,556 shares @ $0.45 ($250,000) in Quoin Pharmaceuticals, Ltd., filed 2024-12-27.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Quoin Pharmaceuticals, Ltd. (QNRX) | Chief Executive Officer, Director | 7 | 6 legs · 613,940 sh · $378,908 | — | 7 |
Form 4 filings — Myers Michael
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-01 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Purchase (P): 20,490 @ $4.88 · Purchase (P): 10,245 (derivative) | EDGAR |
| 2026-02-06 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 318,750 (derivative) @ $0 | EDGAR |
| 2025-06-13 | 4/A | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 42,857 (derivative) @ $0 | EDGAR |
| 2025-06-02 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 42,039 (derivative) @ $0 | EDGAR |
| 2024-12-27 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Purchase (P): 555,556 @ $0.45 · Purchase (P): 555,556 (derivative) · Purchase (P): 555,556 (derivative) | EDGAR |
| 2024-12-10 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Grant/award (A): 536,603 (derivative) @ $0 | EDGAR |
| 2024-09-05 | 4 | Quoin Pharmaceuticals, Ltd. (QNRX) | Purchase (P): 800 @ $0.62 · Purchase (P): 5,322 @ $0.66 · Purchase (P): 8,200 @ $0.75 · Purchase (P): 23,572 @ $0.80 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1959547 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →